Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>)
Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) have?
Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) has 20 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) published?
Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) has 2021 year in the ScholarIQ index.
What is the open-access status of Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>)?
Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) has hybrid oa status in the ScholarIQ index.
What is the DOI of Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>)?
The DOI for Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) is on the source record.
What is the PMID of Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>)?
The PMID for Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) is on the source record.
What is the OpenAlex record for Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>)?
The OpenAlex for Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) is on the source record.